Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STRIDES PHARMA SCIENCE Gains 8%; BSE HEALTHCARE Index Down 0.0%
Tue, 30 Jul 9:46

STRIDES PHARMA SCIENCE Gains 8%; BSE HEALTHCARE Index Down 0.0%Image source: phive2015/www.istockphoto.com

STRIDES PHARMA SCIENCE share price has zoomed 8% and is presently trading at Rs 1,103.0.

Meanwhile, the BSE HEALTHCARE index is at 40,250.9 .

Among the top gainers in the BSE HEALTHCARE index today are Pfizer (up 3.1%) and SUVEN PHARMACEUTICALS (up 2.6%).

FDC (down 2.0%) and MAX HEALTHCARE INSTITUTE (down 1.3%) are among the top losers today.

Over the last one year, STRIDES PHARMA SCIENCE has moved up from Rs 441.8 to Rs 1,103.0, registering a gain of Rs 661.2 (up 149.7%).

On the other hand, the BSE HEALTHCARE index has moved up from 26,979.9 to 40,250.9, registering a gain of 49.2% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 99.2%), Lupin (up 98.5%) and GSK Pharma (up 97.6%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 81,407.3 (up 0.1%).

The top gainers among the BSE Sensex today are NTPC (up 4.3%) and Power Grid Corp. (up 4.0%). The most traded stocks in the BSE Sensex are Power Grid Corp. and NTPC.

In the meantime, NSE Nifty is at 24,883.3 (up 0.2%). Power Grid Corp. and NTPC are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 66,707.2 to 81,407.3, registering a gain of 14,700.1 points (up 22.0%).

STRIDES PHARMA SCIENCE Financial Update...

STRIDES PHARMA SCIENCE net profit grew 239.9% YoY to Rs 801 million for the quarter ended June 2024, compared to a profit of Rs 236 million a year ago. Net sales rose 16.9% to Rs 10,875 million during the period as against Rs 9,300 million in April-June 2023.

For the year ended March 2023, STRIDES PHARMA SCIENCE reported 51.3% increase in net profit to Rs -2,309 million compared to net loss of Rs 4,743 million during FY22. Revenue of the company grew 20.1% to Rs 36,884 million during FY23.

The current Price to earnings ratio of STRIDES PHARMA SCIENCE, based on rolling 12 month earnings, stands at 121.1.


Equitymaster requests your view! Post a comment on "STRIDES PHARMA SCIENCE Gains 8%; BSE HEALTHCARE Index Down 0.0%". Click here!